These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 22543828

  • 21. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation.
    Imai N, Taguchi J, Yagi N, Konishi T, Serizawa M, Kobari M.
    Neuromuscul Disord; 2009 May; 19(5):363-5. PubMed ID: 19269178
    [Abstract] [Full Text] [Related]

  • 22. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 23. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N, Schulenburg A, Mitterbauer M, Keil F, Rabitsch W, Kalhs P, Gisslinger H, Raderer M, Geissler K, Höcker P, Zielinski CC, Oberbauer R, Greinix HT.
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [Abstract] [Full Text] [Related]

  • 24. [A case of POEMS syndrome responding to autologous peripheral blood stem cell transplantation].
    Kanashima H, Yoshida M, Ogawa Y, Nakao T, Nakano S, Inoue T, Yamane T.
    Gan To Kagaku Ryoho; 2013 Apr; 40(4):503-6. PubMed ID: 23848020
    [Abstract] [Full Text] [Related]

  • 25. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
    Demirer T, Uysal VA, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H.
    Bone Marrow Transplant; 2003 May; 31(9):755-61. PubMed ID: 12732881
    [Abstract] [Full Text] [Related]

  • 26. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China.
    Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, Zhao YQ, Shen T.
    Ann Hematol; 2011 Jul; 90(7):819-26. PubMed ID: 21221584
    [Abstract] [Full Text] [Related]

  • 27. Peripheral blood stem cell transplantation for POEMS syndrome.
    Peggs KS, Paneesha S, Kottaridis PD, Chakraverty RK, Tobias G, Reilly M, Mahendra P, Yong K.
    Bone Marrow Transplant; 2002 Sep; 30(6):401-4. PubMed ID: 12235526
    [Abstract] [Full Text] [Related]

  • 28. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B, Jordanova M, Michailov G, Konstantinov D, Christosova I, Bobev D.
    J BUON; 2006 Sep; 11(4):433-8. PubMed ID: 17309174
    [Abstract] [Full Text] [Related]

  • 29. Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study.
    Tribalto M, Amadori S, Cudillo L, Caravita T, Del Poeta G, Meloni G, Avvisati G, Petrucci MT, Pulsoni A, Leone G, Sica S, Martelli M, Tabilio A, Fioritoni G, Majolino I, Mandelli F.
    Haematologica; 2000 Jan; 85(1):52-8. PubMed ID: 10629592
    [Abstract] [Full Text] [Related]

  • 30. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M.
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [Abstract] [Full Text] [Related]

  • 31. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW, Long GD, Stockerl-Goldstein KE, Johnston LJ, Chao NJ, Negrin RS, Blume KG.
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [Abstract] [Full Text] [Related]

  • 32. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
    Kamezaki K, Nagafuji K.
    Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
    [Abstract] [Full Text] [Related]

  • 33. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
    Leung N, Dispenzieri A, Fervenza FC, Lacy MQ, Villicana R, Cavalcante JL, Gertz MA.
    Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045
    [Abstract] [Full Text] [Related]

  • 34. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS, Kim K, Cheong JW, Min YH, Suh C, Kim H, Jo DY, Ryoo HM, Yoon SS, Lee JH, Korean Multiple Myeloma Working Party.
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [Abstract] [Full Text] [Related]

  • 35. [Efficacy of autologous peripheral blood stem cell transplantation (auto-PBSCT) on the neuropathic manifestations in POEMS syndrome].
    Gronier S, Delmont E, Legros L, Launay M, Jeandel PY, Fuzibet JG, Desnuelle C.
    Rev Neurol (Paris); 2014 Jan; 170(1):37-45. PubMed ID: 24411685
    [Abstract] [Full Text] [Related]

  • 36. [Autologous peripheral blood stem cell transplantation for POEMS syndrome].
    Liao LS, Zheng ZH, Qu S, Wei TN, Xie Y, Lin Y, Chen BY, Chen WM.
    Zhonghua Nei Ke Za Zhi; 2019 Mar 01; 58(3):209-212. PubMed ID: 30803180
    [Abstract] [Full Text] [Related]

  • 37. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
    Hong JY, Choi MK, Kim DH, Kim SJ, Kim K, Kim WS, Chung CW, Kim HO, Min YH, Jang JH.
    Transplant Proc; 2010 Nov 01; 42(9):3723-8. PubMed ID: 21094846
    [Abstract] [Full Text] [Related]

  • 38. POEMS syndrome: a rare case of monoclonal plasmaproliferative disorder.
    Oehadian A, Prasetya D, Fadjari TH.
    Acta Med Indones; 2010 Apr 01; 42(2):100-3. PubMed ID: 20513935
    [Abstract] [Full Text] [Related]

  • 39. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patients.
    Molina B, Alonso L, Gonzalez-Vicent M, Andion M, Hernandez C, Lassaletta A, Cormenzana M, Lopez-Ibor B, Villa M, Molina J, Diaz MA.
    Pediatr Hematol Oncol; 2011 Mar 01; 28(2):115-23. PubMed ID: 21299340
    [Abstract] [Full Text] [Related]

  • 40. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T, Zhao A, Zhao H, Cai H, Feng J, Zhang L, Cao X, Zhou D, Li J.
    Ann Hematol; 2019 Mar 01; 98(3):735-743. PubMed ID: 30612232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.